The pharmaceutical industry grapples with an intractable challenge: the escalating cost and protracted timelines of drug development, coupled with persistently…
Read More
From list price to net price: How finance leaders decode real drug costs
In the intricate landscape of the healthcare industry, discussions surrounding drug pricing often commence and conclude with the enigmatic "list…
Read More
Daiichi Sankyo Partners with Interna Therapeutics to Revolutionize Targeted Drug Delivery with Molecular Nano Motor Technology
Boston, MA & Tokyo, Japan – April 17, 2026 – In a significant move to enhance the precision and efficacy…
Read More
Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development
Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…
Read More
Nucleai and Sirona Dx Forge Strategic Alliance to Revolutionize Spatial Proteomics for Drug Development
The pharmaceutical and biotechnology sectors are poised for a significant leap forward in drug development with the formation of a…
Read More
Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
Chinese researchers have unveiled a groundbreaking approach to treating ocular cancers, specifically retinoblastoma, through the development of specialized eye drops…
Read More
Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors
In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Emerging Innovation and Forges Crucial Collaborations in the Drug Discovery Landscape
Boston, MA – Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly…
Read More
Amazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy Development
Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
